DD vs IBO · P/E 127, rev $12.39B vs rev $18.0K
Dupont De Nemours Inc (DD) versus Impact BioMedical, Inc. (IBO) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported IBO revenue for 2025-09-30 was $18.0K. Net income was -$1.5M. IBO currently screens at market cap $7.6M.
DD currently screens at market cap $19.61B and trailing P/E 127.4. IBO currently screens at market cap $7.6M.
Not investment advice. Open the DD and IBO stock pages for the full models.
Not investment advice.